BSDC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.584200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.192400E-01
Normal-vs-Stage2
7.317000E-01
Normal-vs-Stage3
6.189800E-02
Normal-vs-Stage4
3.721400E-01
Stage1-vs-Stage2
4.267600E-01
Stage1-vs-Stage3
7.362100E-02
Stage1-vs-Stage4
5.379400E-01
Stage2-vs-Stage3
1.225410E-01
Stage2-vs-Stage4
1.653640E-01
Stage3-vs-Stage4
3.429700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.188600E-01
Normal-vs-AfricanAmerican
7.403200E-01
Normal-vs-Asian
7.435600E-01
Caucasian-vs-AfricanAmerican
9.933000E-01
Caucasian-vs-Asian
2.749600E-01
AfricanAmerican-vs-Asian
5.893600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.923600E-01
Normal-vs-Female
8.326400E-01
Male-vs-Female
5.016200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.394000E-01
Normal-vs-Age(41-60Yrs)
7.003200E-01
Normal-vs-Age(61-80Yrs)
5.934000E-01
Normal-vs-Age(81-100Yrs)
1.344820E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.924000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.882400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.779800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.718830E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.013300E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.364570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.483200E-01
Normal-vs-Daily Drinker
8.781600E-01
Normal-vs-Weekly Drinker
4.866600E-01
Normal-vs-Occasional Drinker
7.882000E-01
Normal-vs-Social Drinker
8.162400E-01
Non Drinker-vs-Daily Drinker
1.255440E-01
Non Drinker-vs-Weekly Drinker
7.665000E-01
Non Drinker-vs-Occasional Drinker
2.420500E-02
Non Drinker-vs-Social Drinker
3.153700E-02
Daily Drinker-vs-Weekly Drinker
3.424000E-01
Daily Drinker-vs-Occasional Drinker
4.266400E-01
Daily Drinker-vs-Social Drinker
5.122600E-01
Weekly Drinker-vs-Occasional Drinker
1.196830E-01
Weekly Drinker-vs-Social Drinker
1.248010E-01
Occasional Drinker-vs-Social Drinker
8.686800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.172400E-01
Normal-vs-Grade 2
4.769800E-02
Normal-vs-Grade 3
5.574800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.105000E-01
Grade 1-vs-Grade 3
9.842200E-01
Grade 1-vs-Grade 4
2.172400E-01
Grade 2-vs-Grade 3
3.170600E-01
Grade 2-vs-Grade 4
4.769800E-02
Grade 3-vs-Grade 4
5.574800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.900200E-01
Normal-vs-NonDiabetic
8.403800E-01
Diabetic-vs-NonDiabetic
9.089600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.383200E-01
Normal-vs-NoPancreatitis
7.030600E-01
Pancreatitis-vs-NoPancreatitis
9.289700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.269600E-01
Normal-vs-N1
7.357800E-01
N0-vs-N1
6.697400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.455200E-01
Normal-vs-TP53-NonMutant
8.575400E-01
TP53-Mutant-vs-TP53-NonMutant
4.042000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
